CML mouse model in translational research

Methods in Molecular Biology

Volumn 602, Issue , 2010, Pages 253-266

  Peng, Cong ^a   Li, Shaoguang ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

BCR ABL; Chronic myeloid leukemia (CML); hematopoietic stem cell; Philadelphia chromosome (Ph+ chromosome); retroviral mouse model; translational research

Indexed keywords

ANIMALIA;

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; HEAT SHOCK PROTEIN 90; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL MOUSE; CELL LINE; CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSLATIONAL RESEARCH;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL LINE; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FUSION PROTEINS, BCR-ABL; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TRANSLATIONAL RESEARCH;

EID: 77449096075     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-058-8_15     Document Type: Article

References (17)

1. Ren, R. (2005) Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 5, 172-183. (Pubitemid 40314949)
2. Wang, J. C., Lapidot, T., Cashman, J. D., Doedens, M., Addy, L., Sutherland, D. R., et al. (1998) High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91, 2406-2414. (Pubitemid 28155515)
3. Nowell, P. C. and Hungerford, D. A. (1960) Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25, 85-109.
4. Rowley, J. D. (1973) Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293.
5. Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R. and Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36, 93-99. (Pubitemid 14155374)
6. Wong, S. and Witte, O. N. (2004) The BCRABL story: bench to bedside and back. Annu Rev Immunol 22, 247-306. (Pubitemid 38680424)
7. Deininger, M. W., Goldman, J. M. and Melo, J. V. (2000) The molecular biology of chronic myeloid leukemia. Blood 96, 3343-3356.
8. Hariharan, I. K., Harris, A. W., Crawford, M., Abud, H., Webb, E., Cory, S., et al. (1989) A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9, 2798-2805. (Pubitemid 19163041)
9. Heisterkamp, N., Jenster, G., Kioussis, D., Pattengale, P. K. and Groffen, J. (1991) Human bcr-abl gene has a lethal effect on embryogenesis. Transgenic Res 1, 45-53.
10. Castellanos, A., Pintado, B., Weruaga, E., Arevalo, R., Lopez, A., Orfao, A., et al. (1997) A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90, 2168-2174. (Pubitemid 27392700)
11. Inokuchi, K., Dan, K., Takatori, M., Takahuji, H., Uchida, N., Inami, M., et al. (2003) Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis. Blood 102, 320-323. (Pubitemid 36759671)
12. Daley, G. Q., Van Etten, R. A. and Baltimore, D. (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830.
13. Kelliher, M. A., McLaughlin, J., Witte, O. N. and Rosenberg, N. (1990) Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87, 6649-6653.
14. Li, S., Ilaria, R. L., Jr., Million, R. P., Daley, G. Q. and Van Etten, R. A. (1999) The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189, 1399-1412. (Pubitemid 29227526)
15. Hu, Y., Liu, Y., Pelletier, S., Buchdunger, E., Warmuth, M., Fabbro, D., et al. (2004) Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat Genet 36, 453-461. (Pubitemid 38620028)
16. Peng, C., Brain, J., Hu, Y., Goodrich, A., Kong, L., Grayzel, D., et al. (2007) Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells. Blood 110, 678-685. (Pubitemid 47105407)
17. Hu, Y., Swerdlow, S., Duffy, T. M., Weinmann, R., Lee, F. Y. and Li, S. (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci USA 103, 16870-16875. (Pubitemid 44737345)